These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 26662855

  • 1. Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study.
    Yuan JM, Nelson HH, Butler LM, Carmella SG, Wang R, Kuriger-Laber JK, Adams-Haduch J, Hecht SS, Gao YT, Murphy SE.
    Int J Cancer; 2016 May 01; 138(9):2161-71. PubMed ID: 26662855
    [Abstract] [Full Text] [Related]

  • 2. CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study.
    Yuan JM, Nelson HH, Carmella SG, Wang R, Kuriger-Laber J, Jin A, Adams-Haduch J, Hecht SS, Koh WP, Murphy SE.
    Carcinogenesis; 2017 Apr 01; 38(4):411-418. PubMed ID: 28182203
    [Abstract] [Full Text] [Related]

  • 3. Nicotine Metabolism and Smoking: Ethnic Differences in the Role of P450 2A6.
    Murphy SE.
    Chem Res Toxicol; 2017 Jan 17; 30(1):410-419. PubMed ID: 28092945
    [Abstract] [Full Text] [Related]

  • 4. Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
    Park SL, Murphy SE, Wilkens LR, Stram DO, Hecht SS, Le Marchand L.
    PLoS One; 2017 Jan 17; 12(5):e0178435. PubMed ID: 28542511
    [Abstract] [Full Text] [Related]

  • 5. Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity.
    Park SL, Tiirikainen MI, Patel YM, Wilkens LR, Stram DO, Le Marchand L, Murphy SE.
    Carcinogenesis; 2016 Mar 17; 37(3):269-279. PubMed ID: 26818358
    [Abstract] [Full Text] [Related]

  • 6. Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.
    Baurley JW, Edlund CK, Pardamean CI, Conti DV, Krasnow R, Javitz HS, Hops H, Swan GE, Benowitz NL, Bergen AW.
    Nicotine Tob Res; 2016 Sep 17; 18(9):1837-1844. PubMed ID: 27113016
    [Abstract] [Full Text] [Related]

  • 7. Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.
    Zhu AZ, Zhou Q, Cox LS, Ahluwalia JS, Benowitz NL, Tyndale RF.
    PLoS One; 2013 Sep 17; 8(8):e70938. PubMed ID: 23936477
    [Abstract] [Full Text] [Related]

  • 8. Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer.
    Tanner JA, Henderson JA, Buchwald D, Howard BV, Nez Henderson P, Tyndale RF.
    Pharmacogenet Genomics; 2017 May 17; 27(5):169-178. PubMed ID: 28181923
    [Abstract] [Full Text] [Related]

  • 9. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.
    Dempsey D, Tutka P, Jacob P, Allen F, Schoedel K, Tyndale RF, Benowitz NL.
    Clin Pharmacol Ther; 2004 Jul 17; 76(1):64-72. PubMed ID: 15229465
    [Abstract] [Full Text] [Related]

  • 10. Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer.
    Derby KS, Cuthrell K, Caberto C, Carmella SG, Franke AA, Hecht SS, Murphy SE, Le Marchand L.
    Cancer Epidemiol Biomarkers Prev; 2008 Dec 17; 17(12):3526-35. PubMed ID: 19029401
    [Abstract] [Full Text] [Related]

  • 11. Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.
    Ho MK, Mwenifumbo JC, Al Koudsi N, Okuyemi KS, Ahluwalia JS, Benowitz NL, Tyndale RF.
    Clin Pharmacol Ther; 2009 Jun 17; 85(6):635-43. PubMed ID: 19279561
    [Abstract] [Full Text] [Related]

  • 12. Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk.
    Patel YM, Park SL, Han Y, Wilkens LR, Bickeböller H, Rosenberger A, Caporaso N, Landi MT, Brüske I, Risch A, Wei Y, Christiani DC, Brennan P, Houlston R, McKay J, McLaughlin J, Hung R, Murphy S, Stram DO, Amos C, Le Marchand L.
    Cancer Res; 2016 Oct 01; 76(19):5768-5776. PubMed ID: 27488534
    [Abstract] [Full Text] [Related]

  • 13. Biomonitoring of urinary cotinine concentrations associated with plasma levels of nicotine metabolites after daily cigarette smoking in a male Japanese population.
    Nagano T, Shimizu M, Kiyotani K, Kamataki T, Takano R, Murayama N, Shono F, Yamazaki H.
    Int J Environ Res Public Health; 2010 Jul 01; 7(7):2953-64. PubMed ID: 20717551
    [Abstract] [Full Text] [Related]

  • 14. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.
    Malaiyandi V, Goodz SD, Sellers EM, Tyndale RF.
    Cancer Epidemiol Biomarkers Prev; 2006 Oct 01; 15(10):1812-9. PubMed ID: 17035386
    [Abstract] [Full Text] [Related]

  • 15. Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.
    Benowitz NL, St Helen G, Dempsey DA, Jacob P, Tyndale RF.
    Pharmacogenet Genomics; 2016 Jul 01; 26(7):340-50. PubMed ID: 27035242
    [Abstract] [Full Text] [Related]

  • 16. Within-subject variation of the salivary 3HC/COT ratio in regular daily smokers: prospects for estimating CYP2A6 enzyme activity in large-scale surveys of nicotine metabolic rate.
    Lea RA, Dickson S, Benowitz NL.
    J Anal Toxicol; 2006 Jul 01; 30(6):386-9. PubMed ID: 16872570
    [Abstract] [Full Text] [Related]

  • 17. Associations of CYP2A6 genotype with smoking behaviors in southern China.
    Liu T, David SP, Tyndale RF, Wang H, Zhou Q, Ding P, He YH, Yu XQ, Chen W, Crump C, Wen XZ, Chen WQ.
    Addiction; 2011 May 01; 106(5):985-94. PubMed ID: 21205058
    [Abstract] [Full Text] [Related]

  • 18. An association of CYP2A6 genotype and smoking topography.
    Strasser AA, Malaiyandi V, Hoffmann E, Tyndale RF, Lerman C.
    Nicotine Tob Res; 2007 Apr 01; 9(4):511-8. PubMed ID: 17454707
    [Abstract] [Full Text] [Related]

  • 19. Interaction between cytochrome P450 2A6 and Catechol-O-Methyltransferase genes and their association with smoking risk in young men.
    Ou WC, Huang YC, Huang CL, Lin MH, Chen YC, Chen YJ, Liu CN, Chen MC, Huang CS, Chen PL.
    Behav Brain Funct; 2017 May 04; 13(1):8. PubMed ID: 28472995
    [Abstract] [Full Text] [Related]

  • 20. Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers.
    Perez-Paramo YX, Watson CJW, Chen G, Thomas CE, Adams-Haduch J, Wang R, Khor CC, Koh WP, Nelson HH, Yuan JM, Lazarus P.
    Cancer Epidemiol Biomarkers Prev; 2023 Jan 09; 32(1):54-65. PubMed ID: 36252563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.